Get started
Author

Maximilien Moulin

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults
2024 · Romain Deschamps, Jessica Guillaume, et al. · Neurology · 45
Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndrome
2024 · Martin Coly, David Adams, et al. · Journal of Neurology · 11
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
2026 · Marine Boudot de la Motte, Antoine Gavoille, et al. · JAMA Neurology · 7
PDF
Brain atrophy patterns in anti-IgLON5 disease
2025 · Selina M Yogeshwar, Frederik Bartels, et al. · Brain · 7
PDF
Impairment in oral medical comprehension in multiple sclerosis
2020 · N. Ehrlé, M. Moulin, et al. · Revue Neurologique · 6
Explicit and implicit abilities in humor processing in patients with relapsing-remitting multiple sclerosis
2024 · Pauline Gury, Maximilien Moulin, et al. · Social Neuroscience · 4
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database
2026 · Laure Carcaillon-Bentata, Abdelilah Abouelfath, et al. · Multiple Sclerosis and Related Disorders
PDF
Dépistage et diagnostic de la maladie d’Alzheimer par un nouvel outil francophone d’évaluation de la mémoire auditivo-verbale : validation du SMART-9
2026 · Nathalie Wagemann, Maximilien Moulin, et al. · NPG. Neurologie, psychiatrie, gériatrie/NPG
Happy facial emotional congruence in patients with relapsing-remitting multiple sclerosis
2024 · Pauline Gury, Maximilien Moulin, et al. · Journal of Clinical and Experimental Neuropsychology
Troubles du sommeil, mouvements anormaux, cognition, verticalité : anti-IgLON5 ?
2022 · Clément Prévost, Anne Doé de Maindreville, et al. · Revue Neurologique
Works count: 10
Citation count: 80
H-index: 5
I10-index: 2
Year
Topic
Type